Treatment of macrophages with an anti-CD148 monoclonal antibody inhibited macrophage activation, specifically chemotaxis and spreading, induced by the cytokine colony stimulating factor (CSF-1), which taken together suggests that anti-CD148 antibodies may have a potential use in arthritis or other inflammatory diseases [35]. The gene discussed is PTPRJ; the disease is arthritic joint disease.